Abstract
Binding site identification and druggability evaluation are two essential steps in structure-based drug design. A druggable binding site tends to have high binding affinity to drug-like molecules. Predicting such sites can have a significant impact on a drug design campaign. This chapter focuses on summarizing the different methods that are used to predict druggable binding sites. The chapter also discusses the importance of including protein flexibility in the search process and the use of molecular dynamics simulations to address this aspect. Case studies from the literature are also summarized and discussed. We hope that this chapter would provide an overview on the different methods employed in binding site identification evaluation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Nisius B, Sha F, Gohlke H (2012) Structure-based computational analysis of protein binding sites for function and druggability prediction. J Biotechnol 159(3):123–134
Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450(7172):1001–1009
Hajduk PJ, Huth JR, Tse C (2005) Predicting protein druggability. Drug Discov Today 10(23–24):1675–1682
Barakat KH, Mane JY, Tuszynski JA (2011) Virtual screening: an overview on methods and applications, in handbook of research on computational and systems biology. In: Liu L, Wei D, Li Y, Lei H (eds) Handbook of research on computational and systems biology. IGI Global, New York, pp 28–60
Ahmed M, Wang F, Levin A et al (2015) Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA. Drug Discov Today 20(5):548–561
Barakat K (2014) Computer-aided drug design. J Pharma Care Health Sys 1(4):1000e113
Bakan A, Nevins N, Lakdawala AS, Bahar I (2012) Druggability assessment of allosteric proteins by dynamics simulations in the presence of probe molecules. J Chem Theory Comput 8(7):2435–2447
Brown SP, Hajduk PJ (2006) Effects of conformational dynamics on predicted protein druggability. ChemMedChem 1(1):70–72
Seco J, Luque FJ, Barril X (2009) Binding site detection and druggability index from first principles. J Med Chem 52(8):2363–2371
Henrich S, Salo-Ahen OM, Huang B, Rippmann FF, Cruciani G, Wade RC (2010) Computational approaches to identifying and characterizing protein binding sites for ligand design. J Mol Recognit 23(2):209–219
Halgren TA (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49(2):377–389
Barakat KH, Law J, Prunotto A et al (2013) Detailed computational study of the active site of the hepatitis C viral RNA polymerase to aid novel drug design. J Chem Inf Model 53(11):3031–3043
Viricel CM, Ahmed M, Barakat K (2015) Human PD-1 binds differently to its human ligands: a comprehensive modeling study. J Mol Graph Model 57C:131–142
Ahmed M, Barakat K (2015) Baby steps toward modelling the full human programmed Death-1 (PD-1) pathway. Receptors Clin Investig 2(3)
Barakat KH, Huzil JT, Jordan KE, Evangelinos C, Houghton M, Tuszynski J (2013) A computational model for overcoming drug resistance using selective dual-inhibitors for aurora kinase A and its T217D variant. Mol Pharm 10(12):4572–4589
Gajewski MM, Tuszynski J, Barakat K, Huzil JT, Klobukowski M (2013) Interactions of laulimalide, peloruside, and their derivatives with the isoforms of β-tubulin. Can J Chem 91(7):511–517
Gentile F, Tuszynski JA, Barakat KH (2016) New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy. J Mol Graph Model 65:71–82
Hu G, Wang K, Groenendyk J (2014) Human structural proteome-wide characterization of cyclosporine a targets. Bioinformatics 30(24):3561–3566
McClendon CL, Friedland G, Mobley DL, Amirkhani H, Jacobson MP (2009) Quantifying correlations between allosteric sites in thermodynamic ensembles. J Chem Theory Comput 5(9):2486–2502
Eyrisch S, Helms V (2007) Transient pockets on protein surfaces involved in protein-protein interaction. J Med Chem 50(15):3457–3464
Oleinikovas V, Saladino G, Cossins BP, Gervasio FL (2016) Understanding cryptic pocket formation in protein targets by enhanced sampling simulations. J Am Chem Soc 138(43):14257–14263
Ganesan A, Coote ML, Barakat K (2017) Molecular dynamics-driven drug discovery: leaping forward with confidence. Drug Discov Today 22(2):249–269
Perot S, Sperandio O, Miteva MA, Camproux AC, Villoutreix BO (2010) Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov Today 15(15–16):656–667
Brady GP Jr, Stouten PF (2000) Fast prediction and visualization of protein binding pockets with PASS. J Comput Aided Mol Des 14(4):383–401
Levitt DG, Banaszak LJ (1992) POCKET: a computer graphics method for identifying and displaying protein cavities and their surrounding amino acids. J Mol Graph 10(4):229–234
Hendlich MF, Rippmann BG (1997) LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. J Mol Graph Model 15(6):359–363. 389
Goodford PJ (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 28(7):849–857
Laurie AT, Jackson RM (2005) Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics 21(9):1908–1916
Villoutreix BO, Kuenemann MA, Poyet JL (2004) Drug-like protein-protein interaction modulators: challenges and opportunities for drug discovery and chemical biology. Mol Inform 33(6–7):414–437
Bourgeas R, Basse MJ, Morelli X, Roche P (2010) Atomic analysis of protein-protein interfaces with known inhibitors: the 2P2I database. PLoS One 5(3):e9598
Ivetac A, McCammon JA (2010) Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach. Chem Biol Drug Des 76(3):201–217
Landon MR, Lancia DR, Yu J, Thiel SC, Vajda S (2007) Identification of hot spots within druggable binding regions by computational solvent mapping of proteins. J Med Chem 50(6):1231–1240
Miao Y, Nichols SE, McCammon JA (2014) Mapping of allosteric druggable sites in activation-associated conformers of the M2 muscarinic receptor. Chem Biol Drug Des 83(2):237–246
Kozakov D, Grove LE, Hall DR et al (2015) The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nat Protoc 10(5):733–755
Cheng AC, Coleman RG, Smyth KT et al (2007) Structure-based maximal affinity model predicts small-molecule druggability. Nat Biotechnol 25(1):71–75
Makley LN, Gestwicki JE (2013) Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions. Chem Biol Drug Des 81(1):22–32
Fauman EB, Rai BK, Huang ES (2011) Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics. Curr Opin Chem Biol 15(4):463–468
Craig IR, Pfleger C, Gohlke H, Essex JW, Spiegel K (2011) Pocket-space maps to identify novel binding-site conformations in proteins. J Chem Inf Model 51(10):2666–2679
Yang CY, Wang S (2011) Hydrophobic binding hot spots of Bcl-xL protein-protein interfaces by Cosolvent molecular dynamics simulation. ACS Med Chem Lett 2(4):280–284
Schames JR, Henchman RH, Siegel JS, Sotriffer CA, Ni H, McCammon A (2004) Discovery of a novel binding trench in HIV integrase. J Med Chem 47(8):1879–1881
Durrant JD, Keranen H, Wilson BA, McCammon JA (2010) Computational identification of uncharacterized cruzain binding sites. PLoS Negl Trop Dis 4(5):e676
Grant BJ, Lukman S, Hocker HJ et al (2011) Novel allosteric sites on Ras for lead generation. PLoS One 6(10):e25711
Schmidtke P, Bidon Chanal A, Luque FJ, Barril X (2011) MDpocket: open-source cavity detection and characterization on molecular dynamics trajectories. Bioinformatics 27(23):3276–3285
Grove LE, Hall DR, Beglov D, Vajda S, Kozakov D (2013) FTFlex: accounting for binding site flexibility to improve fragment-based identification of druggable hot spots. Bioinformatics 29(9):1218–1219
De Vivo M, Masetti M, Bottegoni G, Cavalli A (2016) Role of molecular dynamics and related methods in drug discovery. J Med Chem 59(9):4035–4061
Lukman S, Nguyen MN, Sim K, Teo JC (2017) Discovery of Rab1 binding sites using an ensemble of clustering methods. Proteins 85(5):859–871
Lee DD, Seung HS (1999) Learning the parts of objects by non-negative matrix factorization. Nature 401(6755):788–791
Hyvarinen A, Oja E (2000) Independent component analysis: algorithms and applications. Neural Netw 13(4–5):411–430
Ortiz-Sanchez JM, Nichols SE, Sayyah J, Brown JH, McCammon JA, Grant BJ (2012) Identification of potential small molecule binding pockets on rho family GTPases. PLoS One 7(7):e40809
Sugita Y, Okamoto Y (2000) Replica-exchange multicanonical algorithm and multicanonical replica-exchange method for simulating systems with rough energy landscape. Chem Phys Lett 329(3–4):261–270
Voter AF (1997) Hyperdynamics: accelerated molecular dynamics of infrequent events. Phys Rev Lett 78(20):3908–3911
Kerrigan JE (2013) Molecular dynamics simulations in drug design. Methods Mol Biol 993:95–113
Mortier J, Rakers C, Bermudez M, Murgueitio MS, Riniker S, Wolber G (2015) The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes. Drug Discov Today 20(6):686–702
Zhao H, Caflisch A (2015) Molecular dynamics in drug design. Eur J Med Chem 91:4–14
Li H, Kasam V, Tautermann CS, Seeliger D, Vaidehi N (2014) Computational method to identify druggable binding sites that target protein-protein interactions. J Chem Inf Model 54(5):1391–1400
Alvarez-Garcia D, Barril X (2014) Molecular simulations with solvent competition quantify water displaceability and provide accurate interaction maps of protein binding sites. J Med Chem 57(20):8530–8539
Guvench O, MacKerell AD Jr (2009) Computational fragment-based binding site identification by ligand competitive saturation. PLoS Comput Biol 5(7):e1000435
Lexa KW, Carlson HA (2011) Full protein flexibility is essential for proper hot-spot mapping. J Am Chem Soc 133(2):200–202
Raman EP, Yu W, Lakkaraju SK, MacKerell AD Jr (2013) Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach. J Chem Inf Model 53(12):3384–3398
Beuming T, Che Y, Abel R, Kim B, Shanmugasundaram V, Sherman W (2012) Thermodynamic analysis of water molecules at the surface of proteins and applications to binding site prediction and characterization. Proteins 80(3):871–883
Masukawa KM, Kollman PA, Kuntz ID (2003) Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations. J Med Chem 46(26):5628–5637
Landon MR, Amaro RE, Baron R et al (2008) Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. Chem Biol Drug Des 71(2):106–116
Shu M, Lin Z, Zhang Y, Wu Y, Mei H, Jiang Y (2011) Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus. J Mol Model 17(3):587–592
Dror RO, Pan AC, Arlow DH et al (2011) Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc Natl Acad Sci U S A 108(32):13118–13123
Overington JP, Al-Lazikani B, Hopkins AL (2006) Opinion - how many drug targets are there? Nat Rev Drug Discov 5(12):993–996
Kappel K, Miao Y, McCammon JA (2015) Accelerated molecular dynamics simulations of ligand binding to a muscarinic G-protein-coupled receptor. Q Rev Biophys 48(4):479–487
Cimermancic P, Weinkam P, Rettenmaier TJ (2016) CryptoSite: expanding the druggable proteome by characterization and prediction of cryptic binding sites. J Mol Biol 428(4):709–719
Petros AM, Olejniczak ET, Fesik SW (2004) Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644(2–3):83–94
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Feng, T., Barakat, K. (2018). Molecular Dynamics Simulation and Prediction of Druggable Binding Sites. In: Gore, M., Jagtap, U. (eds) Computational Drug Discovery and Design. Methods in Molecular Biology, vol 1762. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7756-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7756-7_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7755-0
Online ISBN: 978-1-4939-7756-7
eBook Packages: Springer Protocols